-
21
Immune-metabolic shifts in acute liver failure caused by HEV infection during pregnancy and their association with obstetric outcomes
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
22
Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
23
Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
24
One-stop shop endoscopy for patients with biliary pancreatitis: A Jack of all trades?
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
25
HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients’ clinical stage
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
26
Multidisciplinary clinic model enhances liver and metabolic health outcomes in adults with MASH
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
27
Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
28
Hepatocyte-derived liver progenitor-like cells attenuate liver cirrhosis via induction of apoptosis in hepatic stellate cells
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
29
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
30
FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
31
Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
32
Peroxisome proliferator–activated receptor delta and liver diseases
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
33
Hepatocyte Rho-associated kinase signaling is required for mice to survive experimental porphyria-associated liver injury
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
34
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
35
Adipokines regulate the development and progression of MASLD through organellar oxidative stress
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
36
Short-term costs of alcohol-associated hepatitis care in different clinical settings
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
37
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article -
38
Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
39
The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
Published 2025-01-01“…Annals of Hepatology…”
Get full text
Article -
40
Distribution of culture-positive microorganisms varies with severity of liver disease in patients hospitalized with SBP
Published 2025-02-01“…Hepatology Communications…”
Get full text
Article